Recommended CME For You +++++ ++++ (-)+

Advanced Neuroendocrine Tumors: Integrating Emerging Targeted Therapies Into Patient Care CME https://www.medscape.org/viewarticle/1002665?src=mkmcmr_driv_invit_mscpedu&uac=148436CN Optimizing Outcomes for Thyroid Cancer With NTRK Gene Fusions: Precision Care, Patient Impact CME https://www.medscape.org/viewarticle/1002660?src=mkmcmr_driv_invit_mscpedu&uac=148436CN Managing Patients With HR+/HER2- EBC: Assess Your Knowledge CME https://www.medscape.org/viewarticle/managing-patients-hr-her2-ebc-assess-your-knowledge-2025a1000ier?page=1&src=mkmcmr_driv_invit_mscpedu&uac=148436CN Targeted Therapies for NSCLC: Where Are We Today? CME https://www.medscape.org/viewarticle/1002896?src=mkmcmr_driv_invit_mscpedu&uac=148436CN PTEN Deficiency in Prostate Cancer: Biology, Prognosis, and Therapeutic Relevance CME https://www.medscape.org/viewarticle/pten-deficiency-prostate-cancer-biology-prognosis-and-2025a1000rqh?page=1&src=mkmcmr_driv_invit_mscpedu&uac=148436CN NF-1 Associated Plexiform Neurofibromas in Adults: Which Patients Could Benefit From Emerging Systemic Therapies? CME https://www.medscape.org/viewarticle/1003044?src=mkmcmr_driv_invit_mscpedu&uac=148436CN High-Risk HR-Positive, HER2-Negative Early Breast Cancer: Latest Updates From the European Oncology Congress CME https://www.medscape.org/viewarticle/high-risk-hr-positive-her2-negative-early-breast-cancer-2025a1000udm?page=1&src=mkmcmr_driv_invit_mscpedu&uac=148436CN Expanding the Frontiers of HER2-Targeted Therapy in Gynecologic Cancers CME https://www.medscape.org/viewarticle/expanding-frontiers-her2-targeted-therapy-gynecologic-2025a1000udv?page=1&src=mkmcmr_driv_invit_mscpedu&uac=148436CN Building Consensus in Nonmelanoma Skin Cancer Care: Applying Emerging Science and Best Practices CME Latest Advances in mHSPC: An Update From Berlin 2025 CME https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?page=1&src=mkmcmr_driv_invit_mscpedu&uac=148436CN